One AI firm’s quest to prove value

The latest stories trending on MedCity News.

Editor's Pick

Top Story PR Boasts, CEO Balks: One AI Firm's Quest to Prove Value Ada Health's CEO declined to comment on a bold PR pitch. He contends the company is profitable and at least one health system executive is satisfied with Ada's AI symptom checker. Sponsored Integrated Enrollment Platforms and Consumer Assistance Centers: The Strongest Advantage for State-Based Exchanges Presented by MedCity News & GetInsured In the ever-evolving landscape of state-based health insurance exchanges, the convergence of technology and customer service is reshaping how these exchanges operate. The increasing advent of automation and artificial intelligence (AI) is rapidly dismantling the traditional business model that relies on the siloing of technology and customer service centers. Learn More INVEST Digital Health: Super Early Bird Special Ends Tomorrow Secure the best possible rate for the must-attend event of the season, INVEST Digital Health on September 18 in Dallas! Our Super Early Bird pricing ends this Friday, July 19 at 11:59pm ET, so be sure to grab your discounted tickets now before it's too late to save $150! Hurry, time is running out – act now to take advantage of this exclusive offer before it expires! Save $150, Register NOW

Featured News

What Intermountain Health Hopes to Achieve with its New Behavioral Health Partnership The Salt Lake City health system will pilot NeuroFlow's behavioral health tech platform and services in five primary care locations in Colorado. The first step is to integrate technology into its Epic EHR but the broader goal is to create the mechanism by which behavioral healthcare can be standardized and measured. Thyme Care Raises $95M To Advance Cancer Care Thyme Care's Series C funding round includes investments from Concord Health Partners, CVS Health Ventures, Town Hall Ventures, a16z Bio + Health, AlleyCorp, Echo Health Ventures, Frist Cressey Ventures and Foresite Capital. Roche Weighs In With Encouraging Early Clinical Data for Oral GLP-1 Drug Roche reported its oral GLP-1 agonist led to an average 6.1% weight loss at four weeks, according to preliminary results from part of a Phase 1 study. The small molecule comes from Roche's $2.7 billion acquisition of Carmot Therapeutics last year. Three Remote Nursing Strategies to Fight Patient Burnout As poor experiences and high costs drive many to walk away from their doctors, the right additional support can keep patients from switching providers. Here are three suggestions to consider that could make a difference for patient experience while improving access to care and reducing costs. Traditional Member Engagement is Broken. Daily Care Motivation is the Only Way to Improve Outcomes It's time to hold ourselves to a higher standard. Our industry needs to reimagine what can be accomplished in member engagement by more effectively incorporating behavioral science principles and personalization into our solutions, just as leaders in other industries have done. Breaking the Cycle of Chronic Pain: How Digital Care Can Address a Global Issue As the prevalence of MSK conditions escalates globally, the need for effective, accessible, and equitable care solutions becomes more urgent.

Resources

Debunked | No-Fluff Healthcare News Show | Presented by MedCity News | Episode 6 In this episode, we talk about hospital consolidation and recent Supreme Court decisions affecting healthcare. Companies and organizations mentioned in this episode are Risant Health, Kaiser Permanenete, Cone Health, Geisinger, General Catalyst, Summa Health, FDA, the Supreme Court. Watch Now

MedCity News • PO Box 901 • New York, NY unsubscribe